CEO Steve Lydeamore to Present at AusBiotech 2020
CEO Steve Lydeamore to Present at AusBiotech 2020
Sydney, Oct 9, 2020 AEST (ABN Newswire) - Anatara's CEO, Steve Lydeamore will be presenting to investors at AusBiotech + Invest 2020 on 29th October 2020. Register to attend free for qualified investors.

AusBiotech + Invest 2020 is dedicated to consolidating the sector's growth, and our 2020 conference will once again present issues critical to industry.

Providing a new level of global insight and perspective, keynotes, panel discussions and key themes will cover:

- The global biotech response to COVID-19

- Australia's life sciences industry unites through COVID-19

- The business of biotech

- Regulatory innovation

- Clinical trials

- Medtech and digital health

- Global pharma talks: Search, evaluation and venture investment

- Regenerative medicine and cell therapies

- Therapeutics and personalised medicine

- Health meets agriculture

- Early stage investment

To Register for AusBiotech, please visit:
https://www.abnnewswire.net/lnk/O30B12B3

To view the AusBiotech 2020 Program, please visit:
https://abnnewswire.net/lnk/64ZXQ2TT


About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

    


Contact

Investor and Media inquiries

Steven Lydeamore
Chief Executive Officer
Anatara Lifesciences Ltd
T: +61-438-027-172
E: slydeamore@anatara.com

Sue MacLeman
Chair
Anatara Lifesciences Ltd
T: +61-437-211-200
E: smacleman@anatara.com



Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Since Published: 489)